$949 Million is the total value of Rhenman & Partners Asset Management AB's 83 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 28.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| LLY | New | LILLY ELI & CO | $37,987,380 | – | 81,000 | +100.0% | 4.00% | – |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $32,938,400 | +53.6% | 380,000 | +68.9% | 3.47% | +47.5% |
| CI | Buy | CIGNA CORP NEW | $32,264,791 | +50.3% | 114,985 | +36.1% | 3.40% | +44.3% |
| BSX | Sell | BOSTON SCIENTIFIC CORP | $31,372,200 | +5.4% | 580,000 | -3.3% | 3.31% | +1.2% |
| MCK | Buy | MCKESSON CORP | $30,339,010 | +36.8% | 71,000 | +14.5% | 3.20% | +31.3% |
| UNH | Sell | UNITED HEALTH GROUP INC | $28,838,400 | -19.3% | 60,000 | -21.1% | 3.04% | -22.5% |
| ABT | Buy | ABBOTT LABS | $27,145,980 | +48.1% | 249,000 | +34.6% | 2.86% | +42.2% |
| MDT | Buy | MEDTRONIC PLC | $25,725,200 | +38.3% | 292,000 | +24.3% | 2.71% | +32.7% |
| REGN | Sell | REGENERON PHARMACEUTICALS | $25,148,900 | -12.7% | 35,000 | -1.4% | 2.65% | -16.2% |
| BDX | Sell | BECTON DICKINSON & CO | $25,080,950 | +0.3% | 95,000 | -6.9% | 2.64% | -3.7% |
| ANTM | ELEVANCE HEALTH INC | $24,880,240 | -3.2% | 56,000 | 0.0% | 2.62% | -7.0% | |
| THC | Sell | TENET HEALTHCARE CORP | $23,600,200 | -0.1% | 290,000 | -29.3% | 2.49% | -4.0% |
| ABC | Sell | AMERISOURCEBERGEN CORP | $22,899,170 | -3.5% | 119,000 | -20.1% | 2.41% | -7.4% |
| VRTX | Sell | VERTEX PHARMACEUTICALS INC | $22,346,285 | -14.3% | 63,500 | -24.0% | 2.36% | -17.7% |
| MRK | Sell | MERCK & CO. INC | $21,924,100 | -14.1% | 190,000 | -21.2% | 2.31% | -17.5% |
| HUM | Buy | HUMANA INC | $20,567,980 | +40.4% | 46,000 | +53.3% | 2.17% | +34.8% |
| COO | Sell | COOPER COS INC | $20,245,104 | -19.0% | 52,800 | -22.4% | 2.13% | -22.2% |
| ABBV | Sell | ABBVIE INC | $20,209,500 | -15.8% | 150,000 | -1.3% | 2.13% | -19.2% |
| ZBH | New | ZIMMER BIOMET HOLDINGS INC | $20,092,800 | – | 138,000 | +100.0% | 2.12% | – |
| HCA | Sell | HCA HEALTHCARE INC | $19,574,460 | -10.2% | 64,500 | -23.2% | 2.06% | -13.8% |
| BIIB | Buy | BIOGEN INC | $18,372,825 | +40.6% | 64,500 | +35.8% | 1.94% | +35.0% |
| GILD | Sell | GILEAD SCIENCES INC | $18,034,380 | -14.5% | 234,000 | -9.7% | 1.90% | -17.9% |
| JAZZ | Sell | JAZZ PHARMACEUTICALS PLC | $17,975,650 | -17.3% | 145,000 | -3.3% | 1.90% | -20.6% |
| APLS | Buy | APELLIS PHARMACEUTICALS INC | $17,309,000 | +41.7% | 190,000 | +2.7% | 1.82% | +36.1% |
| CVS | Buy | CVS HEALTH CORP | $17,144,240 | +32.7% | 248,000 | +43.4% | 1.81% | +27.3% |
| EXAS | Buy | EXACT SCIENCES CORP | $16,432,500 | +175.6% | 175,000 | +94.4% | 1.73% | +164.4% |
| SWAV | Sell | SHOCKWAVE MEDICAL INC | $15,982,960 | +11.4% | 56,000 | -16.4% | 1.68% | +7.0% |
| ISRG | Buy | INTUITIVE SURGICAL INC | $15,045,360 | +498.7% | 44,000 | +340.0% | 1.59% | +474.6% |
| DHR | Buy | DANAHER CORPORATION | $14,400,000 | +28.1% | 60,000 | +33.3% | 1.52% | +23.0% |
| IMGN | Sell | IMMUNOGEN INC | $14,152,500 | +205.2% | 750,000 | -40.0% | 1.49% | +193.1% |
| PRVA | Buy | PRIVIA HEALTH GROUP INC | $12,010,600 | +10.6% | 460,000 | +16.3% | 1.27% | +6.2% |
| AXNX | Sell | AXONICS INC | $11,608,100 | -21.3% | 230,000 | -15.1% | 1.22% | -24.4% |
| ALKS | Buy | ALKERMES PLC | $10,955,000 | +191.7% | 350,000 | +159.3% | 1.16% | +180.3% |
| IQV | Buy | IQVIA HLDGS INC | $10,564,190 | +158.0% | 47,000 | +123.8% | 1.11% | +148.1% |
| New | PROCEPT BIOROBOTICS CORP | $9,862,650 | – | 279,000 | +100.0% | 1.04% | – | |
| NTRA | Sell | NATERA INC | $9,732,000 | -17.3% | 200,000 | -7.8% | 1.03% | -20.6% |
| DVAX | Sell | DYNAVAX TECHNOLOGIES CORP | $9,044,000 | +29.3% | 700,000 | -3.4% | 0.95% | +24.1% |
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $8,547,300 | -42.4% | 45,000 | -40.8% | 0.90% | -44.7% |
| LNTH | New | LANTHEUS HLDGS INC | $8,392,000 | – | 100,000 | +100.0% | 0.88% | – |
| TXG | Sell | 10X GENOMICS INC | $7,594,240 | -2.7% | 136,000 | -9.3% | 0.80% | -6.5% |
| KRTX | Sell | KARUNA THERAPEUTICS INC | $7,589,750 | +13.8% | 35,000 | -5.4% | 0.80% | +9.3% |
| BNTX | Sell | BIONTECH SEsponsored ads | $7,555,100 | -33.0% | 70,000 | -23.9% | 0.80% | -35.7% |
| HRMY | Buy | HARMONY BIOSCIENCES HLDGS IN | $7,389,900 | +33.0% | 210,000 | +23.5% | 0.78% | +27.7% |
| OM | Sell | OUTSET MED INC | $7,230,987 | -29.4% | 330,635 | -41.0% | 0.76% | -32.2% |
| VEEV | Sell | VEEVA SYS INC | $6,920,550 | +4.4% | 35,000 | -5.4% | 0.73% | +0.1% |
| GKOS | Buy | GLAUKOS CORP | $6,764,950 | +49.3% | 95,000 | +3.3% | 0.71% | +43.5% |
| MOH | New | MOLINA HEALTHCARE INC | $6,536,908 | – | 21,700 | +100.0% | 0.69% | – |
| CYTK | Sell | CYTOKINETICS INC | $6,524,000 | -7.0% | 200,000 | -2.4% | 0.69% | -10.6% |
| ITCI | Sell | INTRA-CELLULAR THERAPIES INC | $6,015,400 | +2.2% | 95,000 | -9.5% | 0.63% | -1.9% |
| IOVA | Buy | IOVANCE BIOTHERAPEUTICS INC | $5,984,000 | +41.8% | 850,000 | +23.9% | 0.63% | +36.3% |
| ALHC | ALIGNMENT HEALTHCARE INC | $5,750,000 | -7.7% | 1,000,000 | 0.0% | 0.61% | -11.4% | |
| XNCR | Sell | XENCOR INC | $5,618,250 | -18.0% | 225,000 | -10.0% | 0.59% | -21.3% |
| R1 RCM INC | $5,535,000 | +23.4% | 300,000 | 0.0% | 0.58% | +18.5% | ||
| MRNA | New | MODERNA INC | $5,467,500 | – | 45,000 | +100.0% | 0.58% | – |
| IMCR | Sell | IMMUNOCORE HLDGS PLCads | $5,353,109 | -14.2% | 89,278 | -32.0% | 0.56% | -17.7% |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $5,058,200 | -35.9% | 140,000 | -34.9% | 0.53% | -38.5% |
| INSP | Sell | INSPIRE MED SYS INC | $4,999,456 | -45.3% | 15,400 | -59.9% | 0.53% | -47.5% |
| RPRX | Sell | ROYALTY PHARMA PLC | $4,611,000 | -23.0% | 150,000 | -9.1% | 0.49% | -26.1% |
| EVH | New | EVOLENT HEALTH INCcl a | $4,393,500 | – | 145,000 | +100.0% | 0.46% | – |
| HCAT | Sell | HEALTH CATALYST INC | $4,000,000 | +3.4% | 320,000 | -5.9% | 0.42% | -0.7% |
| TECH | Sell | BIO-TECHNE CORP | $3,877,425 | -2.7% | 47,500 | -13.6% | 0.41% | -6.4% |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $3,772,000 | -45.7% | 40,000 | -42.9% | 0.40% | -47.8% |
| Sell | NUVALENT INC | $3,627,084 | +42.7% | 86,011 | -14.0% | 0.38% | +36.9% | |
| MGTX | MEIRAGTX HLDGS PLC | $3,621,986 | +29.5% | 538,986 | 0.0% | 0.38% | +24.4% | |
| WST | Sell | WEST PHARMACEUTICAL SVSC INC | $3,442,230 | -32.7% | 9,000 | -40.0% | 0.36% | -35.3% |
| RVNC | Sell | REVANCE THERAPEUTICS INC | $3,113,130 | -56.5% | 123,000 | -46.5% | 0.33% | -58.3% |
| OLK | Sell | OLINK HLDG ABsponsored ads | $3,112,500 | -18.1% | 166,000 | -4.8% | 0.33% | -21.3% |
| VKTX | VIKING THERAPEUTICS INC | $2,917,800 | -6.5% | 180,000 | 0.0% | 0.31% | -9.9% | |
| AXSM | Buy | AXSOME THERAPEUTICS INC | $2,881,586 | +217.3% | 40,100 | +167.3% | 0.30% | +204.0% |
| EW | Sell | EDWARDS LIFESCIENCES CORP | $2,735,570 | -52.1% | 29,000 | -58.6% | 0.29% | -54.1% |
| RLAY | RELAY THERAPEUTICS INC | $2,386,400 | -21.1% | 190,000 | 0.0% | 0.25% | -24.1% | |
| BBIO | BRIDGEBIO PHARMA INC | $2,322,000 | +0.3% | 135,000 | 0.0% | 0.24% | -3.5% | |
| ARVN | ARVINAS INC | $2,109,700 | -7.4% | 85,000 | 0.0% | 0.22% | -11.2% | |
| NTLA | INTELLIA THERAPEUTICS INC | $2,039,000 | +13.2% | 50,000 | 0.0% | 0.22% | +8.6% | |
| IMVT | New | IMMUNOVANT INC | $1,897,000 | – | 100,000 | +100.0% | 0.20% | – |
| IGMS | Buy | IGM BIOSCIENCES INC | $1,846,000 | +14.2% | 200,000 | +110.5% | 0.20% | +9.6% |
| INMB | New | INMUNE BIO INC | $1,618,819 | – | 178,284 | +100.0% | 0.17% | – |
| ALLO | ALLOGENE THERAPEUTICS INC | $1,491,000 | 0.0% | 300,000 | 0.0% | 0.16% | -4.3% | |
| TGTX | New | TG THERAPEUTICS INC | $1,366,200 | – | 55,000 | +100.0% | 0.14% | – |
| MRSN | Buy | MERSANA THERAPEUTICS INC | $1,316,000 | -6.0% | 400,000 | +14.3% | 0.14% | -9.7% |
| EPIX | ESSA PHARMA INC | $962,550 | -8.5% | 356,500 | 0.0% | 0.10% | -12.2% | |
| RIGL | Sell | RIGEL PHARMACEUTICALS INC | $327,443 | -78.9% | 253,832 | -78.1% | 0.04% | -79.4% |
| TMO | Sell | THERMO FISHER SCIENTIFIC INC | $260,875 | -98.9% | 500 | -98.8% | 0.03% | -98.9% |
| Exit | RAPID MICRO BIOSYSTEMS INC | $0 | – | -127,152 | -100.0% | -0.02% | – | |
| SGMO | Exit | SANGAMO THERAPEUTICS INC | $0 | – | -314,157 | -100.0% | -0.06% | – |
| NKTX | Exit | NKARTA INC | $0 | – | -200,000 | -100.0% | -0.08% | – |
| STXS | Exit | STEREOTAXIS INC | $0 | – | -493,618 | -100.0% | -0.10% | – |
| ESPR | Exit | ESPERION THERAPEUTICS INC NE | $0 | – | -900,000 | -100.0% | -0.16% | – |
| AGL | Exit | AGILON HEALTH INC | $0 | – | -90,000 | -100.0% | -0.23% | – |
| NVCR | Exit | NOVOCURE LTD | $0 | – | -45,000 | -100.0% | -0.29% | – |
| VRAY | Exit | VIEWRAY INC | $0 | – | -1,000,000 | -100.0% | -0.36% | – |
| PHR | Exit | PHREESIA INC | $0 | – | -120,000 | -100.0% | -0.41% | – |
| ISEE | Exit | IVERIC BIO INC | $0 | – | -280,000 | -100.0% | -0.73% | – |
| PODD | Exit | INSULET CORP | $0 | – | -24,000 | -100.0% | -0.84% | – |
| PFE | Exit | PFIZER INC | $0 | – | -190,000 | -100.0% | -0.84% | – |
| SGEN | Exit | SEAGEN INC | $0 | – | -41,000 | -100.0% | -0.91% | – |
| SILK | Exit | SILK RD MED INC | $0 | – | -221,255 | -100.0% | -0.95% | – |
| Exit | LILLY ELI & CO | $0 | – | -105,700 | -100.0% | -3.95% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-11
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UNITEDHEALTH GROUP INC | 40 | Q3 2023 | 4.0% |
| BIOMARIN PHARMACEUTICAL INC | 40 | Q3 2023 | 5.0% |
| ALKERMES PLC | 40 | Q3 2023 | 3.3% |
| LILLY ELI & CO | 39 | Q3 2023 | 5.8% |
| CVS HEALTH CORP | 39 | Q3 2023 | 3.5% |
| INTRA-CELLULAR THERAPIES INC | 39 | Q3 2023 | 2.4% |
| EDWARDS LIFESCIENCES CORP | 39 | Q3 2023 | 1.7% |
| VERTEX PHARMACEUTICALS INC | 38 | Q3 2023 | 4.3% |
| REVANCE THERAPEUTICS INC | 38 | Q3 2023 | 0.9% |
| ABBVIE INC | 37 | Q3 2023 | 4.4% |
View Rhenman & Partners Asset Management AB's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR/A | 2023-11-13 |
| 13F-HR | 2023-11-09 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-11 |
View Rhenman & Partners Asset Management AB's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.